BMC Medicine, 21 (1), 223
A provider may combine a low-dose GLP-1 for appetite regulation with a non-GLP-1 peptide for targeted fat metabolism and muscle preservation
Other strategies are consuming foods and herbs that support kidney health, intermittent fasting, hydration, gently massaging kidney reflex centers, supporting glutathione levels, and detoxing the kidneys with targeted supplementation
Medications like orforglipron (an oral, non-peptide GLP-1 agonist), survodutide (a dual glucagon/GLP-1 agonist), and CagriSema (combining cagrilintide with semaglutide) are advancing through clinical trials
This study suggests that in addition to helping control diabetes and contribute to weight loss, semaglutide at higher doses may help improve HS symptoms
This feedback has led us to explore alternatives to the injectable medications we compound here at Potters House Apothecary